Utilizing advanced cellular models, this study aims to investigate the role of NO in the response to this endocrine treatment, (e.g. estrogen-induced apoptosis) of ER-positive BC cells, in order to better understand, and ultimately reduce, tumor recurrence. This evidence concerns the gene ESR1 and breast cancer.